Healthcare Visits, DMARD Treatment Both Interrupted for Autoimmune Rheumatic Patients During COVID-19

The COVID-19 pandemic impacted virtually all areas of health care, whether it be access to medication, conversions to telemedicine, or a number of other changes. Patients with autoimmune rheumatic diseases have been of particular concern among healthcare providers due to concerns over the worsened effects associated with catching COVID-19 as well as unauthorized delays in … Continue reading Healthcare Visits, DMARD Treatment Both Interrupted for Autoimmune Rheumatic Patients During COVID-19